ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,102.01
0.15%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cocrystal Pharma Inc (COCP) Share Price

COCP Cocrystal Pharma Inc

2.50
-0.1101 (-4.22%)
15 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Cocrystal Pharma Inc NASDAQ:COCP NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.1101 -4.22 2.50 2.33 2.85 2.65 2.30 2.54 53,885 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 2.6M -17.98M -1.7677 -1.35 24.32M
 Type  Size  Price  Time  Units 
 9 50 2.50 22:37:18 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore COCP News
13/05/202413:15EDGAR2Form 8-K - Current report
13/05/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/05/202413:00GLOBECocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
07/05/202421:30EDGAR2Form DEF 14A - Other definitive proxy statements
01/05/202413:00GLOBEEnrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
28/03/202412:00GLOBECocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
19/03/202412:00GLOBECocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
Period
Draw mode
Data Downloads for COCP

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Cocrystal Pharma Inc Articles